An Evaluation of the Effectiveness and Tolerability of Tapentadol Hydrochloride Prolonged Release, and Tapentadol Hydrochloride Immediate Release on Demand, in Subjects With Uncontrolled Severe Chronic Nociceptive, Mixed or Neuropathic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
Latest Information Update: 25 Mar 2019
At a glance
- Drugs Tapentadol (Primary) ; Tapentadol (Primary) ; Tapentadol (Primary) ; Tapentadol (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Grunenthal
- 22 Mar 2019 This trial has been completed in France, according to European Clinical Trials Database.
- 03 Jul 2012 New source identified and integrated: European Clinical Trials Database record 2009-010427-12.
- 16 Apr 2012 Actual patient number is 208 according to ClinicalTrials.gov.